With the aim to identify a DNA methylation based biomarker to stratify breast cancer patients for neoadjuvant treatment with doxorubicin, the methylation status in the promoter regions of 14 genes including ABCB1 has been determined in 75 samples from locally advanced breast cancer [138]. The gene discussed is ABCB1; the disease is breast carcinoma.